## Abstract Seventy‐seven patients were identified with Rare recurring (excluding 11q23, 21q22, inv(16), and t(15;17)) chromosome abnormalities among 511 patients with treatment‐related myelodysplastic syndromes and acute leukemia accepted from centers in the United States, Europe, and Japan. The a
Data management and statistical methods used in the analysis of balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and therapy-related acute leukemia: Report from an International Workshop
✍ Scribed by Theodore Karrison; Kellie J. Archer; Rafael Espinosa III; Ming Wen; Dezheng Huo
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 490 KB
- Volume
- 33
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The Workshop identified 48 unselected patients with therapy‐related myelodysplastic syndrome or acute myeloid leukemia (t‐MDS/t‐AML) and inv(16), and 41 patients with t(15;17) after chemotherapy (CT) and/or radiotherapy (RT) for a malignant or nonmalignant disease. The primary diseases
## Abstract A total of 123 balanced rearrangements, including 26 occurring as a sole anomaly, not known to be recurrent in myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) prior to the Workshop, were ascertained retrospectively from 104 patients with treatment‐related MDS/AML (t‐MDS/
## Abstract Among 511 patients with therapy‐related myelodysplastic syndrome or acute leukemia (t‐MDS/t‐AL) and balanced chromosome aberrations, 162 (32%) had translocations involving 11q23. The recurring translocation partners were 9p22 (48%), 19p13.3 (11%), 19p13.1 (10%), 4q21 (9%), 6q27 (6%), 1p